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Cingulate cortexGenetic variation in the catechol-O-methyltransferase (COMT) Val158Met polymorphism has been shown to
inﬂuence performance on cognitive and emotional tasks. Speciﬁcally, it has been suggested that the Met allele
might be less advantageous than the Val allele with respect to emotional processing.
This study addresses the question whether the presence of the Met allele is directly related to both lower
emotional verbalizing proﬁciency and differences in brain activation during emotional processing.
Speciﬁcally, we investigated whether COMT genotype would be associated with differences in activation in
cortical midline structures during valence evaluation of words.
Forty participants ranging from low to high on the verbalizing subscale of the Bermond–Vorst Alexithymia
Questionnaire (BVAQ) were genotyped for the COMT Val158Met polymorphism. During fMRI, they evaluated
the valence of emotional words.
Met homozygotes reported more difﬁculties in verbalizing their feelings. In addition, the Met allele was
associated with attenuated brain activation in posterior cingulate gyrus and precuneus during valence
evaluation.
We conclude that the Met allele modulates neural activation in regions associated with emotional awareness.
Our ﬁndings may contribute to understanding the neural correlates of susceptibility for affective disorders.Groningen, The Netherlands.
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Catecholaminergic neurotransmission is central to neural circuits
involved in cognitive (Egan et al., 2001; Goldberg et al., 2003) and
affective processing (Bishop et al., 2006; Drabant et al., 2006; Heinz and
Smolka, 2006; Smolka et al., 2005). Catechol-O-methyltransferase
(COMT) is a major enzyme involved in the inactivation of the
catecholamine neurotransmitters including dopamine, epinephrine,
and norepinephrine. The COMT gene has a functional variant involving
the substitution of valine (Val) for methionine (Met) at codon 158
(Val158Met) (Lachman et al., 1996;Mannisto and Kaakkola, 1999). The
Met allele is associated with low enzymatic activity resulting in higher
levels of prefrontal dopamine. Conversely, the Val allele is associatedwith high enzymatic activity and lower levels of prefrontal dopamine
(Chen et al., 2004; Lachman et al., 1996; Mannisto and Kaakkola, 1999).
The Met allele has been associated with several psychiatric disorders
such as panic disorder (Domschke et al., 2004; Woo et al., 2007) and
bipolar affective disorder (Mynett-Johnson et al., 1998; Papolos et al.,
1998). Further, it has been related to increased levels of harmavoidance
(Enoch et al., 2003) and to neuroticism in females (Eley et al., 2003).
At ﬁrst glance, the relationship between COMT Val158Met variation
and cognition and emotion does not seem to be clear-cut. On the one
hand, a number of studies have suggested that Met carriers perform
better on cognitive tasks (Bertolino et al., 2006), accompanied by more
efﬁcient processing as deduced from less task-related activation (Egan
et al., 2001; Goldberg et al., 2003). On the other hand, Met carriers have
been shown to be less proﬁcient compared to Val carriers on emotional
processing tasks (Weiss et al., 2007). Zubieta et al. (2003) reportedMet
homozygotes to show higher sensory and affective ratings of pain and a
more negative internal affective state as compared to Val homozygotes.
Indeed, these authors implied theMet allele to underlie inter individual
differences in less efﬁcient adaptation topain andother stressful stimuli.
Waugh et al. (2009) also hypothesized the Val allele to confer better
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greater perceived social acceptance than didMet homozygotes. A recent
meta-analysis conﬁrmed the pleiotropic effect of COMT Val158Met
variation on cognition with an advantage of the Met allele for cognition
and an advantage of the Val allele for emotion, accompanied by
increased activation in prefrontal areas for the allele carriers that have
reduced ability in the speciﬁc domains (Mier et al., 2010). Drabant et al.
(2006) reported increased cortico-limbic reactivity in Met carriers and
suggested this to underlie emotional dysregulation. In addition,
Williams et al. (2010) reported that COMT genotype modulates
emotion-related brain activity which was related to a higher negativity
bias in Met allele carriers. Furthermore, Montag et al. (2008)
demonstrated that Met carriers exhibited a potentiated startle reﬂex
in reaction to aversive stimuli. There is ample evidence implying that
reduced emotion regulation ability correlates with a stronger startle
reﬂex (Davidson et al., 2000). Lelli-Chiesa et al. (2010) recently reported
that the Met158 allele reduces cortical efﬁciency in the ventrolateral
prefrontal cortex during sad facial affect processing in individuals with
affective disorders. Thus, consistent with the assertion by Smolka et al.
(2005), these studies also point to an association between COMT
genotype and susceptibility for affective disorders.
As COMT genotypes have been associated with difﬁculties in emo-
tional processing, onemay suggest that COMT is related to alexithymia.
Alexithymia is a personality trait characterized by difﬁculties in
describing, identifying and analyzing one's own emotions (Nemiah
and Sifneos, 1970; Sifneos, 1973) and has been associated with
differences in emotional processing (Lane et al., 1996; Luminet et al.,
2006; Suslow, 1998; Swart et al., 2009; Vermeulen et al., 2008, 2006)
and the use of less healthy emotion regulation strategies (Swart et al.,
2009). Alexithymia has been associated with an increased risk for a
variety of psychiatric disorders (Taylor et al., 1997) such as somatization
(Mattila, 2008), depression (Honkalampi et al., 2000), schizophrenia
(van 't Wout et al., 2007) and treatment outcome in anxiety and
somatoform disorder (Bach, 1995). A key component of alexithymia is
the inability to describe one's feelings with words (emotional
verbalizing). Fibromyalgia has been associated with alexithymia
(Huber et al., 2009) and a recent study showed the COMT Met/Met
genotype to be associated with ﬁbromyalgia and higher sensitivity to
pain (Cohen et al., 2009). Another study showed thatMet/Met genotype
was associated with a reduced ability to regulate affective reactivity to
pain in ﬁbromyalgia (Finan et al., 2010). To our knowledge, only one
study directly investigated the association between COMT Val158Met
variation and alexithymia. In contrast to what would be expected from
the literature reviewed above, this study reported that the Val allelewas
associated with higher alexithymia scores (i.e. indicating emotion
regulation problems) on the Toronto Alexithymia Scale-20 (Ham et al.,
2005). However, the ﬁndingwas onlymarginally statistically signiﬁcant
and did not survive correction for a number of tests conducted. The
study also had limited variability in alexithymia scores, as the authors
did not select participants for alexithymia. Based on the weight of the
evidence regarding emotional proﬁciency and COMT Val158Met as
summarized above,we expected to ﬁnd an association between theMet
allele and alexithymia.
This study focused on the relationship between COMT genotype and
both the ability to describe one's feelings and the neural basis under-
lying valence evaluation of emotionalwords. During valence evaluation,
positive and negative words had to be evaluated on subjectively
perceived valence for the participant. This required retrieval of self-
related (emotional) information of the word (i.e. what does this word
mean to me?). In the control condition, the metrical stress of the same
words had to be indicated. This required only retrieval of phonological
aspects of the words. By using the same stimuli in both conditions, we
were able to examine emotional processing controlled for visual word
input and two-choice conﬁguration. By comparing the brain activation
underlying valence evaluation versus metrical stress evaluation, we
might thus be able to identify regions speciﬁc for emotional processing.Given the evidence that Met carriers may be less proﬁcient in
emotional processing (Weiss et al., 2007), they were expected to
report more difﬁculties in describing their feelings, reﬂecting
susceptibility for emotional disorders. In addition, we hypothesized
less activation in Met carriers during valence evaluation in cortical
midline structures, related to self and emotional processing, including
autobiographical memory (Maddock, 1999; Maddock et al., 2003).
Materials and methods
Participants
The study was approved by the medical ethical committee of the
University Medical Center Groningen. The verbalizing scale of the
BVAQ (Vorst and Bermond, 2001) was administered to screen 493
undergraduate university students in order to include individuals
with sufﬁcient variability in emotional verbalizing ability. Participants
who scored in the upper or in the lowest quartile of the scale and
agreed on participating were randomly invited, with the restriction
that half were from the upper quartile and half from the lowest
quartile. 40 right-handed participants (26 females and 14 males,
mean age=21.5, SD=6.2) participated in the experiment. All
participants were free from any lifetime neurological disorder or
psychiatric disorder during the past 10 years and did not take
medication at the time of the experiment. After the MRI session,
participants ﬁlled in the complete BVAQ, there was no evidence for
deviation of normality as tested with the Kolmogorov–Smirnov test
(D (40)=0.13, p=0.09) [skewness=0.54 (0.38); kurtosis=−0.75
(0.74)]. Therefore, we treated alexithymia scores as normally
distributed, which matches well with the idea of the degree of
alexithymia as a continuum in the general population. The current
affective state was measured with the Positive Affect and Negative
Affect Schedule (PANAS) (Watson et al., 1988). COMT genotypes did
not differ on positive affective state (mean=32.2, SD=6.0) nor on
negative affective state (mean=14.8, SD=3.9). After the MRI
session, participants ﬁlled in the entire BVAQ. All 40 participants
were native Dutch speakers and gave written informed consent. They
received €35 for participation.
COMT genotyping
Genotyping of the COMT Val158Met polymorphism (1947G/A;
GenBank Z26491; dbSNP: rs4680) was performed with the allelic
discrimination technique on an Applied Biosystems 7500 real-time
polymerase chain reaction (PCR) system (Applied Biosystems, Nieu-
werkerk a/d IJssel, The Netherlands) according to the protocol supplied
by Applied Biosystems. We used primers COMT-GAF (5′-CGAGAT-
CAACCCCGACTGT-3′) and COMT-GAR (5′-CAGGCATGCACACCTTGTC-
3′), minor groove-binding probes VIC-5′-TTTCGCTGGCGTGAAG-3′-NFQ
(G) and FAM-5′-TCGCTGGCATGAAG-3′-NFQ (A). The reaction was
carried out in TaqMan universal PCR master mix (Applied Biosystems).
Bermond–Vorst Alexithymia Questionnaire
The BVAQ is a 40-item self-report scale, which is subdivided into
ﬁve scales (eight items per scale), comprising the alexithymia features
as deﬁned by Nemiah and Sifneos (1970) (Sifneos, 1973), namely
verbalizing, analyzing, identifying, emotionalizing and fantasizing.
Answers are scored on a 5-point scale (1= certainly does not apply to
me, up to 5= certainly applies tome). High scores indicate high levels
of alexithymia. An example of the verbalizing scale is “I ﬁnd it difﬁcult
to verbally express my feelings”. Previous studies have shown that the
BVAQ has good psychometric properties and that the 5-scale structure
of the BVAQ is supported by factor-analyses (Berthoz et al., 2000;
Berthoz et al., 2007; Vorst and Bermond, 2001; Zech et al., 1999).
Table 1
Demographic information and questionnaire scores by COMT genotype.
Met/Met Val/Met Val/Val Statistic
Mean SD Mean SD Mean SD p
N 10 18 12
Male/female 4/6 6/12 4/8 0.93
Age (years) 23.50 10.10 21.06 4.04 19.90 0.88 0.77
Overall BVAQ (MANOVA) 0.006
BVAQ verbalizing 26.42 9.89 19.44 8.04 16.70 4.40 0.02
BVAQ fantasizing 18.92 5.07 17.44 6.65 20.00 7.77 0.60
BVAQ identifying 16.83 7.32 14.72 4.16 18.10 4.09 0.25
BVAQ emotionalizing 20.33 6.60 21.06 5.74 17.20 4.49 0.24
BVAQ analyzing 17.58 7.60 13.94 3.84 16.60 5.80 0.21
A MANOVA revealed a signiﬁcant effect of COMT genotype on the BVAQ (p=0.006).
Speciﬁcally, Met homozygotes were worse in verbalizing (p=0.02). BVAQ, Bermond–
Vorst Alexithymia Questionnaire; RT, reaction time.
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Valence Evaluation Task (VET)
The Valence Evaluation Task investigated the emotional evaluation
of words during fMRI. This paradigm was presented as a block design.
Bisyllabic Dutch words, which were rated in a previous study by 33
participants, were presented one at a time in the middle of the screen.
Each word was presented for 2 s followed by a ﬁxation cross for 3 s.
Participants had to evaluate the valence (positive or negative) of the
presented word (e.g. stimulus: “summer”; answer e.g. “positive”). As a
control condition, participants had to indicate the syllable that carried
the metrical stress (cf. Aleman et al., 2005). An example would be
“beauty”; where the correct answer would be ‘the 1st syllable’ (see
supplementary table S3).
In both conditions, participants answered by pressing a button on
a response box during the stimulus or just after the stimulus. During
baseline, participants were instructed to ﬁxate on the central cross on
the screen.
In both conditions, 48 stimuli were randomly selected from a list
containing 96 words. Valence (positive/negative) and metrical stress
(1st/2nd syllable) were balanced in each condition. The two
conditions were alternated in blocks of twelve trials of 60 s. Between
the valence evaluation and control blocks, resting blocks of 30 s
(baseline) were included. The total duration of the task was about
12 min.
Image acquisition
Scanning was performed using a 3 T Intera Philips scanner
equipped with a SENSE head coil. For the VET, 39 slices were acquired
with the following parameters using an EPI-sequence (repetition time
(TR) 2500 ms; echo time (TE) 30 ms; and α 80° with an in-plane
resolution of 64×64 pixels (ﬁeld of view (FOV) 224 mm)), resulting
in an isotropic voxel of 3.5 mm.
For anatomical reference, a T1-weighted image (160 slices;
isotropic voxel size of 1 mm; TR 25 ms; TE 4.6 ms; α 30°; and FOV
256 mm) covering the whole brain was acquired.
Data analysis
Genotype data
COMT genotype frequencies were tested for Hardy–Weinberg
proportions using the standard one degree of freedom χ2 test. Age and
gender differences in the different genotype groups were analyzed
with a Kruskal–Wallis test with genotype as factor and gender and age
as dependent variables.
Behavioral data
Group differences were analyzed using SPSS 14 (Norusius, 2002).
Genotype effects on accuracy and reaction times on the VET were
analyzed using regression analyses with accuracy and reaction times
as regressors. Due to technical difﬁculties, behavioral data were not
recorded for two subjects during the VET. Genotype differences on the
positive and negative affect scales were analyzed using ANOVA. The
subscales of the BVAQ were analyzed with a multivariate analysis of
variance (MANOVA). In case of signiﬁcant differences, a regression
analysis was performed to test for a gene-dosage effect.
Imaging data
Data were analyzed with Statistical Parametric Mapping (SPM5; FIL
Wellcome Department of Imaging Neuroscience, London, UK). After
realignment, the functional images were coregistered to the T1-
weighted image. The anatomical image was normalized to a standard
T1 MNI (Montreal Neurological Institute) brain and the same
transformation was applied to the functional images. The latter were
then smoothed with a Gaussian kernel (full width at half maximum
8 mm). For the analyses of the VET, one participant (Val/Val genotype)was excluded because of excessive movement (N3 mm). At the ﬁrst
level, two separate regressors were modeled for valence evaluation
blocks and metrical stress blocks with a boxcar function convolving a
hemodynamic response function. For each participant, two ﬁrst level
contrasts were deﬁned: 1) to detect genotype dependent effects on
emotional evaluation, we deﬁned the contrast: valence evaluation–
metrical stress evaluation; and 2) to analyze the effect of genotype on
processing of emotional words in general (i.e. across conditions), we
made the contrast: valence evaluation+metrical stress evaluation.
First, to detect associations between COMT genotype and valence
evaluation compared to metrical stress evaluation, the contrast
images (valence evaluation–metrical stress evaluation) of all partici-
pants were included in a regression analysis in SPM5. COMT genotype
wasmodeled as the number of Met alleles (0, 1 or 2). The analysis was
thresholded at pb0.001 with an extent threshold of 20 voxels.
Additionally, we controlled for multiple comparisons with a family-
wise error (FWE) correction of pb0.05 at a cluster level. In a similar
way, the contrast images valence evaluation+metrical stress evalu-
ation were included in a regression analysis. For the effect of task,
irrespective of genotype, the contrast images were entered into a
random effects analysis (RFX).
For further inspection of activation differences between groups,
we entered valence evaluation versus rest and metrical stress
evaluation versus rest into separate RFX analyses for the Met
homozygotes and Val homozygotes.
To control for potential confounding of genotype effects by gender,we
performed the same analysis with gender added as a covariate. To control
for potential confounding of reaction time differences between genotypes
during valence evaluation, we performed the same analysis with
individual reaction time during valence evaluation added as a covariate.
As genotype and verbalizing are related to each other, it is difﬁcult to
control for the possible confounding effect of verbalizing. Therefore, to
examine the (possible confounding) effect of verbalizing, we conducted
two additional analyses. Firstly, we performed a regression analysis with
verbalizing score as a regressor (without genotype). Secondly, we
performed a regression analysis with genotype as a regressor and
verbalizing score as a covariate. For the additional analyses with a
covariate, we used the pb0.001 threshold with an extent threshold of 20
voxels to preserve sensitivity due to a reduction in degrees of freedom.
Results
Table 1 presents demographical data and questionnaire scores by
genotype.
Genotyping
Out of the 40 participants, twelve participants (30%) (eight
women) were homozygous for the Met158 allele and ten (25%) (six
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eighteen participants (45%) (twelve women) were heterozygous.
Allele and genotype frequencies were in Hardy–Weinberg propor-
tions (χ2=0.38, df=1; p=0.54). Genotype was not associated with
gender (χ2=0.14, df=2; p=0.93) nor with age (χ2=0.53, df=2;
p=0.77).
Questionnaire data
COMT genotype had a signiﬁcant effect on the subscales of the
BVAQ (Pillai's Trace F(10,68)=2.80, p=0.006). Between-subjects
effects revealed that COMT genotypes differed on the verbalizing
subscale (F(2,37)=4.56, p=0.02). A post-hoc regression analysis
demonstrated that the number of Met alleles was positively
correlated with verbalizing score (i.e. more difﬁculties in emotional
verbalizing) (R2=0.18, b=0.43, p=0.006) (see Fig. 1). No other
signiﬁcant differences were obtained. The distribution of the COMT
genotypes in the invited groups of low and high verbalizing score was
respectively: (Val/Val, Val/Met, Met/Met): 7/9/4 and 3/9/8.
Behavioral data
With regard to the VET, the number of Met alleles was positively
associated with reaction times of valence evaluation (R2=0.11,
b=0.33, p=0.02) (Met/Met: M=1250.9, SD=244.4; Val/Met:
M=1192.9, SD=208.6; Val/Val: M=1041.3, SD=172.4). The number
of Met alleles was not associated with reaction times of metrical stress
evaluation (control condition) (p=0.90) (Met/Met: M=1391.7,
SD=269.2; Val/Met: M=1522.8, SD=369.9; Val/Val: M=1387.6,
SD=431.6) nor with accuracy (p=0.73) (mean percent correct
responses Met/Met: 81%; Val/Met: 77%; Val/Val: 79%) (in the valence
evaluation condition there are no correct or incorrect answers).
Participants assigned to 52% of the words a negative valence and to
48% a positive valence. Therewere no differences between genotypes in
valence assignment (p=0.13).
Imaging data
Valence Evaluation Task
The contrast valence evaluation versus metrical stress evaluation
yielded brain activation in the bilateral precuneus, bilateral dorsome-
dial prefrontal cortex and right supramarginal gyrus (see Fig. 2 and
Table S1 in the supplementary information).0 Met/Met Val/Met Val/Val
30
0
10
20
COMT genotype
M
ea
n 
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Fig. 1. Mean verbalizing scores per COMT genotype. The number of Met alleles was
positively correlated with verbalizing score (i.e. less verbalizing proﬁciency) (p=0.02).
Error bars represent the standard error of the mean.COMT Val158Met genotype effect on the Valence Evaluation Task
The regression analysis for the contrast valence evaluation versus
metrical stress evaluation demonstrated a signiﬁcant negative
correlation between the number of Met alleles and activation in the
left precuneus and bilateral cingulate gyrus (PCC) extending into the
precuneus and medial frontal gyrus (MFC) (see Fig. 3 and Table 2).
There was no genotype dependent effect on the processing of
emotional words in general as demonstrated by the regression analysis
with the contrast valence evaluation+metrical stress evaluation.
An examination of the within group contrasts valence evaluation
versus ﬁxation and metrical stress evaluation of the homozygotes
revealed that the homozygote groups showed different deactivations
during these conditions (pb0.001). The Met/Met genotype showed
approximately the same deactivation in PCC during both valence
evaluation and metrical stress evaluation. The Val/Val genotype also
showed approximately the same deactivation as theMet/Met genotype
in response to metrical stress evaluation. However, in response to
valence evaluation, the Val/Val genotype had less deactivation in PCC
(see supplementary information Fig. S1).
When we controlled for gender, the relation between COMT
genotype and activation in PCC extending into precuneus and in MFC
remained signiﬁcant with identical peak activations, indicating that
the effect of COMT genotype was independent from gender (see
supplementary information Table S2). When we controlled for
reaction time during valence evaluation, the same regions remained
signiﬁcant, indicating that there was no confounding effect of this
covariate in our ﬁndings.
The additional analyses to examine the (confounding) effect of
verbalizing demonstrated that an increased verbalizing score was
related to decreased activation inMFC (peakmaximum (x, y, z):−12,
−24, 66). This cluster neighbored and slightly overlapped the cluster
in the cingulate cortex related to genotype. The regression analysis
with verbalizing score added as a covariate demonstrated that the
relation between COMT genotype in both the cingulate cortex and
precuneus/cuneus remained signiﬁcant with the same peak maxima
((x, y, z): 8, −22, 50 and −18, −74, 20, respectively) although the
size of the clusters decreased.
We did not ﬁnd any signiﬁcant positive correlation between the
number of Met alleles and brain activation.
Discussion
The primary ﬁnding of our study was that the number of Met
alleles was associated with less activation in cortical midline
structures (CMS) during valence evaluation of emotional words. In
addition, individuals with a higher number of Met alleles reported to
have more difﬁculties in verbalizing their feelings, a core aspect of
alexithymia. Our results lend further support to the relevance of CMS
for emotional awareness and suggest an involvement of these areas in
emotion regulation and disorders thereof.
With regard to self-reported emotion regulation, the Met allele
presented a dosage effect on difﬁculties in emotional verbalizing. This
suggests an involvement of the Met allele in alexithymia, which is a
novel ﬁnding. Previous research has shown that individuals scoring
high on alexithymia in general or more speciﬁcally on the subscale
verbalizing, performed worse on emotion recognition tasks (Lane
et al., 1996; Swart et al., 2009). Our ﬁnding regarding a role of COMT
Met alleles in emotion concurs with a previous behavioral study of
emotion processing inMet carriers (Weiss et al., 2007), which showed
Met carriers to be less proﬁcient than Val homozygotes in recognition
of emotional expressions. A previous study (Ham et al., 2005) in a
Korean sample reported that the number of Val alleles was correlated
with higher alexithymia scores on the Toronto Alexithymia Scale. As
the current study points toward an association of the COMTMet allele
alexithymia, replication studies are required to solve this issue. Of
note, our ﬁnding of a relationship between the Met allele and emotion
Fig. 2. Brain activation during valence evaluation across groups was in dorsomedial prefrontal cortex and cuneus/precuneus. Contrasted versus metrical stress evaluation (correction
for multiple comparison with FWE-correction at cluster level pb0.05 with a cluster size of N20 voxels) and superimposed on a single subject T1 image (x=−4, y=−52, z=28).
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emotional resilience in COMT Met allele carriers (Montag et al., 2008;
Smolka et al., 2005; Williams et al., 2010). Thus, based on our results
and most other studies into COMT and emotion processing, we
suggest that theMet allele is related to emotion regulation difﬁculties.
During valence evaluation, we found that the bilateral precuneus,
posterior cingulate cortex (PCC) and dorsomedial prefrontal cortex
weremore activated as comparedwith activation duringmetrical stress
evaluation. In line with our ﬁndings, prior imaging studies reported
increased activation in the precuneus, medial prefrontal cortex and PCC
during valence evaluation of emotional words (Maddock et al., 2003;
Posner et al., 2009) and IAPS pictures (Paradiso et al., 1999). Thus, our
and other ﬁndings suggest that the medial prefrontal cortex, posterior
cingulate cortex and precuneus react to the emotionality of the stimulus
(Lee and Siegle, 2009;Maddock et al., 2003; Posner et al., 2009) and that
this reﬂects the activation of autobiographical memory (for a meta-
analysis see Svoboda et al., 2006). Also, meta-analyses have conﬁrmed
that self-referential processing is mediated by cortical midline struc-
tures (Northoff et al., 2006; vanderMeer et al., 2010).With regard to theFig. 3. Effect of COMT genotype on activation during valence evaluation. Met allele load
was associated with decreased activation in posterior cingulate gyrus and cuneus/
precuneus. Task contrasted against control task and superimposed on a sliced single
subject T1 image (x=−2, y=−26, z=50) and on a rendered (below right) image
(correction for multiple comparisons with FWE-correction at cluster level pb0.05 with
a cluster size of N20).COMT genotypes, with increasing the number of Met alleles, activation
decreased in the PCC and precuneus during valence evaluation. Met
homozygotes have previously been associated with attenuated PCC
activation in a sentence completion task in people athigh genetic risk for
psychosis (McIntosh et al., 2007). In addition, a PET study (Slifstein et al.,
2008) found that Met allele carriers showed a decrease in D1 receptors
both in cortical (amongst others: medial prefrontal and parietal
cortices) and limbic areas (amygdala and hippocampus). The authors
suggested that this polymorphismmay also affect the function of these
regions (Slifstein et al., 2008).
Our ﬁnding of attenuated activation in Met carriers in PCC and
precuneus is, as far aswe know, the ﬁrst evidence that COMTmodulates
activation in corticalmidline structures in relation to valence evaluation.
As cortical midline structures play a role in self-related processes
including emotional awareness (Dimaggio et al., 2009; van der Meer
et al., 2010), decreased activation might be related to lower emotional
awareness. Additionally, the Met carriers responded more slowly to
valence evaluation, which might imply that they had more difﬁculties
performing this task. A possible interpretation of our ﬁndings could be
that, because Met homozygotes are worse in describing their feelings,
andmayhave lower levels of emotional awareness (cf. Laneet al., 1997),
they activate their autobiographical memory to a lesser extent. Thus,
areas related to autobiographical memory (and more speciﬁcally the
PCC)may be less activated. Indeed,Mantani et al. (2005) have observed
less PCC activation during imagining future events in individuals with
high alexithymia as compared to individuals low in alexithymia.
It is difﬁcult to disentangle the speciﬁc effect of COMTor alexithymia
on brain activation, as these variables are correlated. Therefore, we
examined the effect of COMT genotype on activation with verbalizing
score as a covariate andwe investigated theeffect of verbalizingwithout
genotype. The effect of genotype was stronger than the effect ofTable 2
Brain areas which were negatively related with the number of Met alleles during
valence evaluation.
Area BA Side k T Z Peak maxima
(MNI coordinates)
x y z
Cingulate cortex, precuneus,
medial frontal cortex
(paracentral lobule)
31,
6
L, R 1687 5.17 4.46 8 −22 50
4.73 4.16 12 −40 62
4.6 4.07 −10 −28 46
Supramarginal gyrus, superior
temporal gyrus
40 L 198 5.1 4.41 −58 −60 26
4.02 3.64 −50 −50 34
Rolandic operculum, superior
temporal gyrus
13,
41
R 200 4.48 3.98 40 −32 24
4.31 3.86 44 −28 12
Precuneus, cuneus 31,
18
L 197 4.24 3.8 −18 −74 20
4.11 3.71 −6 −78 22
3.95 3.58 −2 −68 16
Correction for multiple comparisons with FWE-correction at cluster level pb0.05 with a
cluster size of N20 voxels. BA, Brodmann areas; L, left; R, right; k, number of voxels;
MNI, Montreal Neurological Institute.
343M. Swart et al. / NeuroImage 55 (2011) 338–344verbalizing on brain activation related to valence evaluation. Addition-
ally, the activation in cingulate cortex was not explained by verbalizing
score. Therefore, we suggest that the activation in PCC is mainly
explained by COMT genotype.
Interestingly, PCC activation has been associated with self-related
processes during rest and self-referential aspects of tasks and with
deactivation during non self-related tasks (Dimaggio et al., 2009;
Raichle et al., 2001; van der Meer et al., 2010). To examine the PCC
activations or deactivations, we compared the valence evaluation
condition with rest (visual ﬁxation) and the metrical stress condition
with rest in Met and Val homozygotes separately. Both groups
deactivated the PCC equally duringmetrical stress evaluationwhereas
during valence evaluation the Met homozygotes deactivated the PCC
more than the Val homozygotes. The difference in deactivation may
also imply that the Met homozygotes recruit autobiographical
memory to a lesser extent during valence evaluation.
Only a few imaging studies have investigated COMT polymor-
phisms in relation to emotional processing, with inconsistent results.
More Met alleles have been associated with decreased activation in
prefrontal areas during viewing the IAPS pictures used as distracters
in a house matching task (Bishop et al., 2006), but also with increased
activation in prefrontal areas in response to passively viewing the
IAPS pictures (Smolka et al., 2005). In addition, less activation in
amygdala and right temporal pole during labeling facial expressions
have been shown in Met homozygotes (Kempton et al., 2009)
whereas an increased activation have been shown in right hippo-
campal formation and right VLPFC during matching facial expressions
(for a review see Aleman et al., 2008; Drabant et al., 2006). Differences
in task design might play a role in these inconsistencies, in addition to
regional speciﬁcity in cognitive functions of frontal areas. In an
attempt at integration, Smolka et al. (2005) have speculated that
COMT Met allele carriers might have difﬁculties to recruit prefrontal
regulatory regions under demanding conditions.
It is of importance to note that our results are based on the ﬁndings
from young and healthy participants with a limited sample size.
Methylation of the COMT gene (inﬂuenced by aging, nutrition and life
events, a.o.) can lead to changes in gene activity, and hence different
results may be achieved in older samples due to epigenetic
mechanisms (cf. Abdolmaleky, 2006). More research is necessary to
further enhance our understanding of the neural differences related to
COMT genotype.
The relevance for psychiatric disorders also deserves further
elucidation. Although a recent meta-analysis did not ﬁnd a direct
link between COMT and schizophrenia (Okochi, 2009) or depression
(Lopez-Leon et al., 2008), they might be indirectly linked via an
intermediate phenotype as expressed by neural systems related to
emotion processing. Our ﬁndingmay eventually result in new insights
into the complex relationship between COMT genotype and emo-
tional processing underlying both normal variation in affective
processing and susceptibility to affective disorders.
In conclusion, we demonstrated that difﬁculties in emotional
verbalizing are positively related to the number of Met alleles. In
addition, an increase in the number of Met alleles resulted in a
decrease of neural activation in PCC. This might be associated with
lower emotional awareness, which in turn may be related to
susceptibility for affective disorders.Acknowledgments
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